WallStreetZenWallStreetZen

NASDAQ: SLGL
Sol Gel Technologies Ltd Stock Forecast, Predictions & Price Target

Analyst price target for SLGL

Based on 2 analysts offering 12 month price targets for Sol Gel Technologies Ltd.
Min Forecast
$4.00+488.24%
Avg Forecast
$5.00+635.29%
Max Forecast
$6.00+782.35%

Should I buy or sell SLGL stock?

Based on 2 analysts offering ratings for Sol Gel Technologies Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SLGL stock forecasts and price targets.

SLGL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-19
lockedlocked$00.00+00.00%2024-05-22

1 of 1

Forecast return on equity

Is SLGL forecast to generate an efficient return?
Company
13.57%
Industry
-388.81%
Market
59.09%
SLGL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SLGL forecast to generate an efficient return on assets?
Company
11.27%
Industry
27.33%
SLGL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SLGL earnings per share forecast

What is SLGL's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.57
Avg 2 year Forecast
-$0.49
Avg 3 year Forecast
-$0.30

SLGL revenue forecast

What is SLGL's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$8.5M+29.59%
Avg 2 year Forecast
$8.2M+24.87%
Avg 3 year Forecast
$9.7M+47.89%
SLGL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SLGL revenue growth forecast

How is SLGL forecast to perform vs Biotechnology companies and vs the US market?
Company
11.86%
Industry
34.98%
Market
9.26%
SLGL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SLGL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SLGL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLGL$0.68$5.00+635.29%Buy
AIM$0.33$5.00+1,424.39%Buy
EVAX$3.45$11.00+218.84%Strong Buy
SPRB$0.45$2.50+458.04%Buy
NKGN$0.78N/AN/A

Sol Gel Technologies Stock Forecast FAQ

Is Sol Gel Technologies Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SLGL) stock is to Buy SLGL stock.

Out of 2 analysts, 0 (0%) are recommending SLGL as a Strong Buy, 2 (100%) are recommending SLGL as a Buy, 0 (0%) are recommending SLGL as a Hold, 0 (0%) are recommending SLGL as a Sell, and 0 (0%) are recommending SLGL as a Strong Sell.

If you're new to stock investing, here's how to buy Sol Gel Technologies stock.

What is SLGL's earnings growth forecast for 2024-2026?

(NASDAQ: SLGL) Sol Gel Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Sol Gel Technologies's earnings in 2024 is -$14,915,000.On average, 2 Wall Street analysts forecast SLGL's earnings for 2024 to be -$15,878,843, with the lowest SLGL earnings forecast at -$23,121,825, and the highest SLGL earnings forecast at -$8,635,862. On average, 2 Wall Street analysts forecast SLGL's earnings for 2025 to be -$13,510,946, with the lowest SLGL earnings forecast at -$15,321,691, and the highest SLGL earnings forecast at -$11,700,200.

In 2026, SLGL is forecast to generate -$8,357,286 in earnings, with the lowest earnings forecast at -$8,357,286 and the highest earnings forecast at -$8,357,286.

What is SLGL's revenue growth forecast for 2024-2026?

(NASDAQ: SLGL) Sol Gel Technologies's forecast annual revenue growth rate of 11.86% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.98%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.26%.

Sol Gel Technologies's revenue in 2024 is $6,559,000.On average, 2 Wall Street analysts forecast SLGL's revenue for 2024 to be $236,789,770, with the lowest SLGL revenue forecast at $139,288,100, and the highest SLGL revenue forecast at $334,291,440. On average, 2 Wall Street analysts forecast SLGL's revenue for 2025 to be $228,153,908, with the lowest SLGL revenue forecast at $203,360,626, and the highest SLGL revenue forecast at $252,947,190.

In 2026, SLGL is forecast to generate $270,218,914 in revenue, with the lowest revenue forecast at $270,218,914 and the highest revenue forecast at $270,218,914.

What is SLGL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SLGL) forecast ROA is 11.27%, which is lower than the forecast US Biotechnology industry average of 27.33%.

What is SLGL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SLGL price target, the average SLGL price target is $5.00, with the highest SLGL stock price forecast at $6.00 and the lowest SLGL stock price forecast at $4.00.

On average, Wall Street analysts predict that Sol Gel Technologies's share price could reach $5.00 by Aug 19, 2025. The average Sol Gel Technologies stock price prediction forecasts a potential upside of 635.29% from the current SLGL share price of $0.68.

What is SLGL's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: SLGL) Sol Gel Technologies's current Earnings Per Share (EPS) is -$0.54. On average, analysts forecast that SLGL's EPS will be -$0.57 for 2024, with the lowest EPS forecast at -$0.83, and the highest EPS forecast at -$0.31. On average, analysts forecast that SLGL's EPS will be -$0.49 for 2025, with the lowest EPS forecast at -$0.55, and the highest EPS forecast at -$0.42. In 2026, SLGL's EPS is forecast to hit -$0.30 (min: -$0.30, max: -$0.30).

What is SLGL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SLGL) forecast ROE is 13.57%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.